ADAM NAVONE: Open Payments
NPI 1124414040 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 12 payments from 8 companies in 2025. Trend: 2023 $683 · 2024 $773 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| PFIZER INC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: QULIPTA, Veozah, OPSUMIT, VRAYLAR, M-M-R II, Ozempic, UBRELVY, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
